Introduction to the database "efficacy of different treatment modalities for lower respiratory tract infections in

Yu Deng1, Bing Hu2, Yingxue Zou3

  • 1Department of Respiratory Center Children's Hospital of Chongqing Medical University National Clinical Research Center for Child Health and Disorders Ministry of Education Key Laboratory of Child Development and Disorders Chongqing Key Laboratory of Child Infection and Immunity Chongqing China.

Pediatric Discovery
|October 2, 2025
PubMed

Insights

A new registry database for pediatric lower respiratory tract infections (LRTIs) in China was established. It details clinical characteristics and treatments for 4805 children, aiding future research on rational drug use.

Area of Science:

  • Pediatric Infectious Diseases
  • Medical Informatics
  • Clinical Data Management

Background:

  • Lower respiratory tract infections (LRTIs) are a significant health concern in children.
  • There is a need for comprehensive data on LRTIs in Chinese children, including clinical characteristics and treatment patterns.
  • Existing knowledge gaps hinder the optimization of rational drug use and treatment strategies.

Purpose of the Study:

  • To establish a multicenter registry database for pediatric LRTIs in China.
  • To collect and analyze clinical data on LRTIs in Chinese children.
  • To provide a platform for information exchange and improve research efficiency.

Main Methods:

  • A multicenter, observational study was conducted.
  • Data from 4805 pediatric patients with LRTIs were collected and pooled.
  • Medical informatics and statistical techniques were used for data analysis.

Main Results:

  • The registry database was preliminarily established with a cohort of 4805 patients.
  • Pneumonia (72.44%) and acute bronchitis (20.71%) were the most common LRTIs.
  • The highest incidence of pneumonia and acute bronchitis was observed in children aged 1-3 and 3-6 years, respectively.

Conclusions:

  • The established database provides valuable real-world data on LRTIs in Chinese children.
  • This resource elucidates clinical characteristics and treatment modalities for pediatric LRTIs.
  • The database will facilitate further research into clinical patterns and rational drug use.

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
756
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.1K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
462
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
629